1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Impact of COVID-19
on Global Peripheral Blood Mononuclear Cells Market
5. Voice of Customer
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application
for Which PBMCs Are Used
5.4. Factors Driving
Market Growth
6.
Global Peripheral Blood Mononuclear Cells Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or
Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability
Kits)
6.2.2. By Application (Immunology, Infectious Disease,
Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and
Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South
America, Middle East & Africa)
6.2.6. By Company (2021)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7.
North America Peripheral Blood Mononuclear Cells Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.
By
Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States
Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Application
7.3.1.2.3.
By Technique
7.3.1.2.4.
By Source
7.3.2. Canada Peripheral
Blood Mononuclear Cells Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Application
7.3.2.2.3.
By Technique
7.3.2.2.4.
By Source
7.3.3. Mexico Peripheral
Blood Mononuclear Cells Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Application
7.3.3.2.3.
By Technique
7.3.3.2.4.
By Source
8.
Europe Peripheral Blood Mononuclear Cells Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1.
By
Product
8.2.2.
By
Application
8.2.3.
By
Technique
8.2.4.
By Source
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. Germany Peripheral
Blood Mononuclear Cells Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Application
8.3.1.2.3.
By Technique
8.3.1.2.4.
By Source
8.3.2. France Peripheral
Blood Mononuclear Cells Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Application
8.3.2.2.3.
By Technique
8.3.2.2.4.
By Source
8.3.3. United Kingdom
Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Application
8.3.3.2.3.
By Technique
8.3.3.2.4.
By Source
8.3.4. Italy Peripheral
Blood Mononuclear Cells Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Application
8.3.4.2.3.
By Technique
8.3.4.2.4.
By Source
8.3.5. Spain Peripheral
Blood Mononuclear Cells Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Application
8.3.5.2.3.
By Technique
8.3.5.2.4.
By Source
9.
Asia-Pacific Peripheral Blood Mononuclear Cells Market
Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1.
By
Product
9.2.2.
By
Application
9.2.3.
By
Technique
9.2.4.
By Source
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Peripheral
Blood Mononuclear Cells Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Application
9.3.1.2.3.
By Technique
9.3.1.2.4.
By Source
9.3.2. Japan Peripheral
Blood Mononuclear Cells Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Application
9.3.2.2.3.
By Technique
9.3.2.2.4.
By Source
9.3.3. India Peripheral
Blood Mononuclear Cells Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Application
9.3.3.2.3.
By Technique
9.3.3.2.4.
By Source
9.3.4. South Korea
Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Application
9.3.4.2.3.
By Technique
9.3.4.2.4.